Health
Oncologists use immunotherapy at faster rates for trial-ineligible patients, study finds – News-Medical.Net
Cancer patients who are ineligible for clinical trials receive immune checkpoint inhibitors (ICI) at greater rates than patients…
Cancer patients who are ineligible for clinical trials receive immune checkpoint inhibitors (ICI) at greater rates than patients who are trial eligible despite no survival benefit, according to a new study by researchers at the Perelman School of Medicine…
Continue Reading
-
Noosa News21 hours agoStudents say new facility would be better in rural areas of Queensland
-
General15 hours ago‘We are here for you’: PM to bring help to flood zones
-
General13 hours agoWe’ve all talked about potential economic consequences for Australia of Trump’s policies. Now they’re happening
-
Noosa News13 hours agoRates on hold; pressure builds for cuts in May